Home > Healthcare & Medical Devices > Burn Care Market
Burn Care Market size is expected to gain consistent traction in the coming years, generating substantial revenue by 2032. Some of the major upcoming trends in the market will be influenced by the growing number of burn injuries caused due to fire breakouts and other accidents. In the U.S. alone, more than 60% of acute hospital admissions are related to burn injury, according to the American Burn Association (ABA). In addition, the rising demand for minimally invasive solutions for treating burns will propel the market growth.
With constant efforts by government and regulatory organizations, as well as the information available on the internet, there has been increased public awareness regarding the different options available for the treatment and management of burns, both at home and in healthcare institutions. Robust expenditure in healthcare infrastructure, especially in developing regions, will positively impact the burn care market by 2032.
Globally, increasing consumer focus on aesthetic appearance is being observed, leading to an increased demand for skin grafts and other procedures. The availability of a wide variety of biologics for burn wound treatment providing benefits such as faster wound healing, cost efficiency, and shorter hospital stay, will augment the market expansion.
The negative impacts of the Russia-Ukraine conflict are globally foreseen across many regions, including the European Union, Eastern Europe, the United States, and Eastern & Central Asia. The contention has severely impacted people’s lives and livelihoods and designates far-reaching disturbances in trade dynamics. The potential consequences of ongoing war and uncertainty are expected to adversely impact the burn care market in Ukraine and resonate drastic long-term outcomes in Russia. Alongside this, the high inflation in developed economies has led to an overall price surge in the past two years.
The cumulatively deteriorating purchasing power is anticipated to impact the burn care business across developing economies, attributed to the limited patient footfalls in hospitals and clinics for minor burn injuries. Besides, a noticeable decline in healthcare expenses may further hamper the market value in the next ten years.
Considering the product landscape, the advanced dressings segment is likely to capture a fair share of the burn care market through 2032. The segment includes hydrogel dressings, collagen dressings, alginate dressings, hydrocolloid dressings, foam dressings, film dressings, wound contact layers, and others. These products provide numerous advantages, such as ease of use, cost efficiency, and shorter recovery time.
Among these, hydrogel dressings are poised to witness robust demand. These dressings are generally used for treating blistering wounds. Hydrogel dressings consist of a layer of hydrating polymer that alleviates pain and provides moisture to accelerate healing.
Regarding the depth of the burn, the burn care market share from the partial-thickness burn segment is set to garner noticeable gains by 2032. Based on estimates by the U.S. FDA, each year, roughly 40,000 people are hospitalized due to partial burns. Biologics such as advanced dressings and skin grafts are being extensively utilized for treating partial burns, thus, fueling segment expansion. Besides, favorable reimbursement policies across several developed countries for patients suffering from partial burns will positively influence market dynamics.
Geographically, the North America burn care market is slated to record notable gains from 2023 to 2032. The American Burn Association (ABA) reports that more than 450,000 severe burn injuries occur in the U.S. each year, requiring specialized medical treatment. To raise awareness regarding the treatment and management of burns, the ABA declared the first week of February National Burn Awareness Week. Similar campaigns by other health and public safety organizations will certainly foster regional revenue.
3M Company, Smith & Nephew, Medtronic, Derma Sciences (Integra LifeSciences Holdings Corporation), Coloplast, Convatec, Mölnlycke Health Care, and Acelity (3M Company) are some of the established names in the market.